Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Breast Cancer Comprehensive Panel Fulgent Genetics United States | 52 | 20 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Hematologic Malignancy Comprehensive Panel Fulgent Genetics United States | 39 | 16 |
|
Fulgent Genetics United States | 29 | 12 |
|
Fulgent Genetics United States | 33 | 15 |
|
Fulgent Genetics United States | 40 | 14 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 138 | 80 |
|
Syndromes with immunodeficiency Panel CeGaT GmbH Germany | 33 | 38 |
|
Bone marrow failure syndromes Panel CeGaT GmbH Germany | 15 | 37 |
|
Fulgent Genetics United States | 3 | 1 |
|
Fulgent Genetics United States | 6 | 1 |
|
Fulgent Genetics United States | 5 | 1 |
|
Chromosomal Instability Syndromes NGS Panel Fulgent Genetics United States | 16 | 7 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Fulgent Genetics United States | 322 | 75 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1058 | 554 |
|
Fulgent Genetics United States | 76 | 51 |
|
Dyskeratosis Congenita NGS Panel Fulgent Genetics United States | 14 | 8 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.